Get Mesothelioma Vs Reactive Mesothelial Cells Immunohistochemistry Background

Get Mesothelioma Vs Reactive Mesothelial Cells Immunohistochemistry
Background. Please type a message to the paper's authors to explain your need for the paper. (2017) reactive mesothelial hyperplasia versus mesothelioma.

Use Of Panel Of Markers In Serous Effusion To Distinguish Reactive Mesothelial Cells From Adenocarcinoma Subbarayan D Bhattacharya J Rani P Khuraijam B Jain S J Cytol
Use Of Panel Of Markers In Serous Effusion To Distinguish Reactive Mesothelial Cells From Adenocarcinoma Subbarayan D Bhattacharya J Rani P Khuraijam B Jain S J Cytol from www.jcytol.org

Mesothelioma is an aggressive cancer that affects the lungs, heart, abdomen or testiciles. Reactive mesothelial cells may appear atypical or show mitoses. (2017) reactive mesothelial hyperplasia versus mesothelioma.

Cytologic effusions, immunohistochemical markers, malignant mesothelioma, reactive mesothelial hyperplasia.

The use of immunohistochemistry to distinguish reactive mesothelial cells from malignant mesothelioma in cytologic effusions. Fish to distinguish malignant mesothelioma from reactive mesothelial cells in effusions had 79% sensitivity 1. Malignancies involving mesothelial cells that normally line the body cavities, including the pleura, peritoneum, pericardium, and testis, are known as malignant mesothelioma. The use of immunohistochemistry to distinguish reactive mesothelial cells from malignant mesothelioma in cytologic effusions.